低剂量组合3或4种降血压药物用于治疗高血压
Nelson Wang1, Phidias Rueter2, Abdul Salam3
1The George Institute for Global Health, University of New South Wales, Sydney, Australia; Cardiology Department, Royal Prince Alfred Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia.
JACC. Advances
|June 24, 2025
概括
单片低剂量组合药 (LDCs) 有效降低血压 (BP),并且对于初始高血压治疗是安全的. 它们的有效性与患者的基线血压水平有关.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 低剂量组合 (LDC) 的3或4降血压 (BP) 药物在一个单一的药片显示潜在的启动高血压治疗.
- 高血压管理通常涉及复杂的药物治疗方案,突出需要简化治疗选择.
研究的目的:
- 评估单片LDC治疗高血压的有效性和安全性.
- 在随机对照试验中,将LDC与安慰剂,单疗法和常规护理进行比较.
主要方法:
- 随机试验的系统搜索和元分析,比较LDC (3-4种药物,标准剂量≤0.5) 与安慰剂,单疗法或常规护理.
- 评估平均血压降低,达到血压<140/90毫米升的比例,以及不良事件风险.
主要成果:
- 最低发达国家显著降低了血压,与安慰剂相比降低了14/6毫米升,与单疗法相比降低了7/6毫米升.
- 低血压治疗将血压控制率提高到67%,而单一治疗为46%.
- 以最不发达国家为基础的护理在降低和控制血压方面表现优于通常的护理,但不良事件相关的退出没有显著增加.
结论:
- 单片LDC代表高血压的有效和安全的初始治疗策略.
- 通过LDCs实现的血压降低程度受到患者治疗前血压的显著影响.
- 最不发达国家提供了一种简化且有效的方法,从一开始就对高血压进行管理.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
54
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
54
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Alterations in Blood Pressure
1.5K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.5K
Hypertension V: Nursing Management
50
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
50
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524


